| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1106945587 |
| P356 | DOI | 10.1186/S12957-018-1490-7 |
| P932 | PMC publication ID | 6137719 |
| P698 | PubMed publication ID | 30213266 |
| P2093 | author name string | Nan Zhang | |
| Li Yin | |||
| Xia He | |||
| Qian Fei | |||
| Jiajia Gu | |||
| P2860 | cites work | Current status in remnant gastric cancer after distal gastrectomy | Q26764928 |
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 | ||
| The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. | Q31133052 | ||
| Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. | Q34488692 | ||
| A pilot study of preoperative chemoradiotherapy for resectable gastric cancer | Q34516350 | ||
| Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction | Q34603020 | ||
| Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer | Q34616795 | ||
| Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial | Q34627996 | ||
| Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial | Q34634440 | ||
| Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection | Q34638268 | ||
| Combined-modality therapy for gastric cancer | Q35597396 | ||
| Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial | Q36950483 | ||
| EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach | Q37449362 | ||
| Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy | Q38043755 | ||
| Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis | Q38092435 | ||
| Radiotherapy for gastric cancer: a systematic review and meta-analysis | Q38127627 | ||
| Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis. | Q38226324 | ||
| Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis. | Q38285881 | ||
| CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response | Q38379668 | ||
| Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States. | Q39841938 | ||
| A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer | Q40023074 | ||
| Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma | Q40520874 | ||
| Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer | Q43620764 | ||
| Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome | Q44019896 | ||
| Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma | Q44978576 | ||
| Locally advanced adenocarcinomas of the gastric cardia: results of pre-operative chemoradiotherapy | Q45221303 | ||
| The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. | Q46373510 | ||
| Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy | Q46825524 | ||
| Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. | Q53242132 | ||
| Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection. | Q53361535 | ||
| A new approach to delineating lymph node target volumes for post-operative radiotherapy in gastric cancer: A phase II trial. | Q53399831 | ||
| A new suggestion for the radiation target volume after a subtotal gastrectomy in patients with stomach cancer. | Q53550807 | ||
| Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation | Q59115813 | ||
| Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial | Q62628533 | ||
| Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial | Q74599960 | ||
| Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation | Q77711975 | ||
| Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients | Q77737282 | ||
| Evaluation of the toxicity of the combined treatment of chemoradiotherapy, according to the scheme of Macdonald, after radical surgery in patients diagnosed of gastric cancer | Q80212991 | ||
| A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection | Q84981772 | ||
| Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials | Q87088158 | ||
| Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database | Q88495157 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human digestive system | Q9649 |
| stomach neoplasm | Q4335552 | ||
| P304 | page(s) | 187 | |
| P577 | publication date | 2018-09-13 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Progress of preoperative and postoperative radiotherapy in gastric cancer | |
| P478 | volume | 16 |
| Q92846576 | Application value of CyTOF 2 mass cytometer technology at single-cell level in human gastric cancer cells |
| Q92512125 | B7-H3 increases the radioresistance of gastric cancer cells through regulating baseline levels of cell autophagy |
| Q99608812 | Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer |
| Q92798849 | MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1 |
| Q93022479 | The relative survival and cure fraction of gastric cancer estimated through flexible parametric models using data from population-based cancer registration during 2003-2012 in Linzhou, China |
Search more.